Antares Pharma (ATRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -25,079 | -17,892 | -8,795 | -20,507 | -14,872 |
| Depreciation Amortization | 892 | 521 | 240 | 703 | 463 |
| Accounts receivable | -1,238 | -2,031 | -2,614 | 1,199 | -1,177 |
| Accounts payable and accrued liabilities | -221 | -1,084 | -1,145 | 2,529 | 1,388 |
| Other Working Capital | 1,811 | 3,028 | 972 | 2,335 | -419 |
| Other Operating Activity | 3,357 | 4,318 | 4,380 | -1,227 | 1,323 |
| Operating Cash Flow | $-20,478 | $-13,139 | $-6,961 | $-14,968 | $-13,294 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 21,000 | 15,000 | 6,000 | 24,000 | 15,000 |
| PPE Investments | -2,830 | -918 | -129 | -2,743 | -2,185 |
| Purchase Of Investment | N/A | N/A | N/A | -21,130 | -9,118 |
| Purchase Sale Intangibles | -462 | -253 | -42 | -420 | -196 |
| Other Investing Activity | -462 | -253 | -42 | -420 | -196 |
| Investing Cash Flow | $17,708 | $13,829 | $5,829 | $-293 | $3,502 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 2,909 | 1,416 | 1,237 | 2,327 | 757 |
| Other Financing Activity | -154 | -154 | -115 | -104 | -104 |
| Financing Cash Flow | $2,754 | $1,261 | $1,122 | $2,223 | $652 |
| Exchange Rate Effect | -1 | -1 | 0 | 9 | 4 |
| Beginning Cash Position | 39,067 | 39,067 | 39,067 | 52,097 | 52,097 |
| End Cash Position | 39,051 | 41,018 | 39,058 | 39,067 | 42,961 |
| Net Cash Flow | $-16 | $1,951 | $-10 | $-13,030 | $-9,137 |
| Free Cash Flow | |||||
| Operating Cash Flow | -20,478 | -13,139 | -6,961 | -14,968 | -13,294 |
| Capital Expenditure | -2,830 | -918 | -129 | -2,743 | -2,185 |
| Free Cash Flow | -23,307 | -14,057 | -7,090 | -17,712 | -15,479 |